a nonsignificant trendP = 0.078
Compared with DMSO, there was a nonsignificant trend towards lower viability with auranofin ( P = 0.078), obatoclax ( P = 0.055), and INK-128 ( P = 0.094).
Compared with DMSO, there was a nonsignificant trend towards lower viability with auranofin ( P = 0.078), obatoclax ( P = 0.055), and INK-128 ( P = 0.094).